Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,882 JPY | -0.69% | +1.37% | -11.81% |
Apr. 10 | Mani's Fiscal H1 Attributable Profit Jumps 25% on Higher Net Sales | MT |
Apr. 09 | Transcript : Mani, Inc., Q2 2024 Earnings Call, Apr 09, 2024 |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 30.85 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.64% | 1.18B | C- | ||
-4.91% | 183B | C+ | ||
+0.46% | 108B | C | ||
-3.62% | 67.51B | A | ||
+3.26% | 50.67B | B- | ||
+9.11% | 44.7B | B- | ||
+3.43% | 40.95B | B+ | ||
+6.39% | 26.8B | B | ||
+3.83% | 26.71B | A- | ||
+14.34% | 24.62B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 7730 Stock
- Ratings Mani, Inc.